What is the Difference Between Allogeneic and Autologous Transplant?

The main difference between allogeneic and autologous transplants lies in the source of the stem cells used for the transplant. Here are the key differences between the two types of transplants:

Allogeneic Transplants: In this type of transplant, the stem cells come from a donor, either a matched related or unrelated donor. The term "allogeneic" comes from the word "allo," which means other. There are two types of allogeneic transplants: myeloablative transplants and reduced-intensity allogeneic transplants.
Autologous Transplants: In this type of transplant, the stem cells come from the same person who will receive the transplant, making the patient their own donor. The term "autologous" comes from the word "auto," which means self.

Advantages and disadvantages of each type of transplant include:

Allogeneic Transplants: With allogeneic transplants, there is a possibility of the "graft-versus-cancer" effect, in which the donor immune cells from the transplant help kill any cancer cells that remain. However, these transplants carry a higher risk of complications, such as graft failure and graft-versus-host disease, as well as a higher treatment-related mortality rate.
Autologous Transplants: Autologous transplants have a lower risk of life-threatening complications, no risk of graft-versus-host disease, and no need for immunosuppressive therapy. Immune reconstitution is more rapid after autologous transplants, and treatment-related mortality is lower than with allogeneic transplants. However, autologous transplants may still fail, and the transplanted stem cells might not effectively destroy any remaining cancer cells.

The choice between an allogeneic or autologous transplant depends on factors such as the type of malignancy, the age of the recipient, the availability of a suitable donor, the ability to collect a tumor-free autograft, the stage and status of the disease, and the malignancy's susceptibility to graft-versus-malignancy effects.

On this page

What is the Difference Between Allogeneic and Autologous Transplant?

Comparative Table: Allogeneic vs Autologous Transplant

Here is a table comparing the differences between allogeneic and autologous transplants:

Feature	Allogeneic Transplant	Autologous Transplant
Donor	Patient's stem cells come from another person (unrelated or related)	Patient's stem cells come from the patient themselves
Immune Response	Provides a graft-versus-tumor (GVT) effect, as the donor's immune cells attack the patient's cancer cells. This can lead to graft-versus-host disease (GVHD) as the donor's immune cells attack healthy tissue in the patient.	No GVT effect, as the patient's own stem cells are used, reducing the risk of GVHD.
Conditioning	More intense conditioning regimens are often used to eliminate residual tumor cells and ensure engraftment.	Less intense conditioning regimens are used, as the focus is on resetting the patient's immune system rather than treating the underlying disease.
Indications	Typically used when a patient has an aggressive, refractory, or relapsed disease, and a search for a suitable donor is conducted.	Primarily used for frontline management of multiple myeloma and to reset the patient's immune system, particularly their T cells.
Prevalence	Allogeneic transplants are less common due to the need for a suitable donor and the potential for complications.	Autologous transplants are more common and can be performed more easily as the patient is their own donor.

Both allogeneic and autologous transplants have their own advantages and disadvantages, and the choice between them depends on the patient's specific condition and status.

Guilherme Mazui

Guilherme Mazui is graduated in journalism from the Federal University of Minas Gerais (UFMG) and a master's degree in Communication from the University of São Paulo (USP). In addition, he has experience in advertising writing and has worked as a content editor in several companies.